Home Healthcare Medical Devices Home Infusion Therapy Market

Home Infusion Therapy Market Size, Share & Trends Analysis Report By Type (Products, Services), By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 27, 2026 | Author: Debashree Bora | Format:

Home Infusion Therapy Market Size & Growth Analysis

The global home infusion therapy market size was valued at USD 41.65 billion in 2025 and is projected to grow from USD 44.99 billion in 2026 to USD 83.47 billion by 2034, registering a CAGR of 8.03% during the forecast period from 2026 to 2034. North America dominated the home infusion therapy market with a market share of 42.6% in 2025.

 The rising prevalence of chronic diseases, including diabetes, cancer, and immune disorders, is driving demand for long-term intravenous therapies administered at home. The International Diabetes Federation 2025 stated that approximately 589 million adults aged 20-79 are living with diabetes.

Clinical studies indicate that home infusion can lower hospitalization rates by over 20% while enhancing patient satisfaction and adherence.Expanding aging populations and increased preference for cost-effective care settings further accelerate market growth. Opportunities are emerging through partnerships with home healthcare providers, specialty pharmacies, and digital health platforms.

Home Infusion Therapy Market Key Takeaways

Global Market Size & Growth

2025 Market Size
USD 41.65 Billion
2026 Market Size
USD 44.99 Billion
2034 Projected Market Size
USD 83.47 Billion
Forecast Period
2026–2034
Base Year
2025
Market CAGR (2026–2034)
8.03%

Regional Insights

Largest Regional Market (2025)
North America
North America Market Share (2025)
42.6%
Fastest-Growing Region
Asia Pacific
Asia Pacific CAGR (2026–2034)
10.3%

Segment Insights

By Type
Leading Segment
Products
Market Share in 2025 61.5%
By Product
Fastest-Growing Segment
Infusion Pumps
CAGR 8.7% (2026–2034)
By Application
Leading Segment
Anti-Infective
Market Share in 2025 24.7%
Home Infusion Therapy Market Size

Download a Free Sample To learn more about this report.

Home Infusion Therapy Market Dynamics

01

Rising Prevalence of Chronic Diseases and Increasing Need for Prolonged Infusion Therapies Support Home Infusion Therapy Market Growth

The increasing prevalence of cancer, diabetes, immune deficiencies, chronic infections, and other conditions requiring prolonged medication administration is expanding the overall need for infusion therapies. The growing use of intravenous antibiotics, immunoglobulins, specialty pharmaceuticals, nutrition therapies, and other infused treatments is increasing demand for reliable infusion services across healthcare settings and supporting continued market growth.

01

High Costs and Complex Care Coordination Requirements Can Limit Home Infusion Therapy Adoption

Home infusion therapy requires infusion equipment, medications, nursing support, patient training, vascular access management, monitoring, and coordination among healthcare providers and pharmacies. These requirements can increase service costs and operational complexity, particularly for patients with limited caregiver support or healthcare systems with restricted reimbursement coverage.

01

Expansion of Specialty Pharmaceuticals and Complex Therapies in Home Settings Creates New Growth Opportunities

The growing availability of biologics, immunoglobulin therapies, specialty pharmaceuticals, anti-infectives, and other complex treatments is expanding the range of therapies that can potentially be delivered at home. Improvements in patient selection, clinical support, portable infusion technologies, and remote monitoring can enable more high-value therapies to transition from institutional settings to coordinated home-care programs.

01

Maintaining Infection Control, Patient Safety, and Reliable Clinical Monitoring Creates Challenges

Home infusion therapy requires strict medication handling, vascular access care, infection-control procedures, accurate device operation, and timely clinical intervention when complications occur. Delivering these requirements outside controlled healthcare facilities can create challenges related to patient training, caregiver capability, monitoring consistency, emergency response, and maintaining high standards of clinical quality.

Home Infusion Therapy Market Segmentation

By Type

The products segment accounted for a share of 61.5% in 2025, owing to the widespread use of infusion pumps, intravenous solutions, administration sets, and other medical products required for home-based infusion therapy. the increasing adoption of home healthcare and growing demand for convenient and cost-effective treatment options further strengthen the segment’s dominant position in the home infusion therapy market.

The services segment is expected to grow at a CAGR of 8.9% during the forecast period, driven by increasing demand for skilled home infusion care, growing preference for home-based treatment, and rising need for patient monitoring and clinical support. the expansion of home healthcare services and increasing availability of specialized infusion therapy providers further support the segment’s growth.

Home Infusion Therapy Market Size By Segments

Request Customizationto receive a tailored report.

By Product

The infusion pumps segment accounted for a 43.2% share in 2025 and is expected to grow at a CAGR of 8.7% during the forecast period 2026-2034, driven by increasing demand for controlled and accurate drug delivery, growing adoption of home-based infusion therapy, and rising prevalence of chronic conditions requiring long-term treatment. the increasing use of portable and technologically advanced infusion pumps further strengthens the segment’s dominant position in the home infusion therapy market.

The intravenous sets segment supports the administration of medications and fluids during infusion therapy, while the IV cannulas segment enables reliable vascular access for home-based treatments. the needleless connectors segment contributes to safer and more convenient infusion procedures by reducing needle-related risks and supporting efficient connections within infusion systems.

By Application

The anti-infective segment accounted for a share of 24.7% in 2025 due to the widespread use of home infusion therapy for administering antibiotics and other anti-infective medications, along with the growing need for long-term treatment of infections. the increasing preference for home-based care and the need to reduce hospital stays further strengthen the segment’s dominant position in the home infusion therapy market.

The specialty pharmaceuticals segment is expected to grow at a CAGR of 9.4% during the forecast period, fueled by increasing use of complex biologic and specialty medicines, growing prevalence of chronic and complex diseases, and rising demand for home-based administration of specialized therapies. the endocrinology segment supports infusion-based treatment for diabetes and other endocrine disorders, while the hydration therapy segment contributes through fluid replacement and management of dehydration. the chemotherapy segment supports cancer treatment through home-based administration of selected therapies, while the enteral nutrition segment provides nutritional support for patients unable to consume adequate nutrition orally. the parenteral nutrition segment supports patients requiring intravenous nutritional therapy.

Home Infusion Therapy Market Share By Segments

Speak to an Analystto discuss market opportunities.

Home Infusion Therapy Market Regional Outlook

North America Home Infusion Therapy Market Analysis

North America home infusion therapy market accounted for 42.6% of the global market, reaching USD 17.74 billion in 2025, and is projected to grow at a CAGR of 7.9% during the forecast period. The market is driven by increasing prevalence of chronic diseases, growing demand for home-based healthcare, rising healthcare costs, and increasing preference for convenient and personalized treatment options. Expanding home healthcare infrastructure and advancements in infusion technologies continue to support regional market growth.

US Home Infusion Therapy Market Insights

The US market was valued at USD 15.08 billion in 2025, making it the largest contributor in North America. Increasing demand for home-based treatment, growing prevalence of chronic conditions, rising healthcare expenditure, and expanding adoption of portable infusion devices continue to drive market growth.

Canada Home Infusion Therapy Market Insights

Canada's market reached USD 2.66 billion in 2025. Growing demand for home healthcare services, increasing aging population, expanding access to infusion therapy, and rising adoption of advanced home infusion technologies continue to support steady market expansion.

North America Home Infusion Therapy Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Home Infusion Therapy Market Analysis

Europe home infusion therapy market accounted for 27.8% of the global market, reaching USD 11.58 billion in 2025, and is projected to grow at a CAGR of 7.6% during the forecast period. Increasing prevalence of chronic diseases, growing adoption of home healthcare services, rising healthcare expenditure, and increasing demand for cost-effective treatment alternatives continue to strengthen regional market growth. Expanding healthcare infrastructure and greater patient preference for home-based care further support market expansion.

UK Home Infusion Therapy Market Insights

The UK market was valued at USD 2.32 billion in 2025. Increasing demand for community-based healthcare, growing prevalence of chronic diseases, expanding home treatment programs, and rising adoption of advanced infusion technologies continue to support market growth.

Germany Home Infusion Therapy Market Insights

Germany market accounted for USD 3.24 billion in 2025. Strong healthcare infrastructure, increasing demand for home-based medical care, growing elderly population, and rising investments in advanced infusion systems continue to drive market expansion.

Asia Pacific Home Infusion Therapy Market Analysis

Asia Pacific home infusion therapy market accounted for 19.7% of the global market, reaching USD 8.21 billion in 2025, and is projected to grow at a CAGR of 10.3% during the forecast period. Rapid healthcare infrastructure development, increasing prevalence of chronic diseases, growing healthcare expenditure, and rising demand for home-based treatment continue to accelerate regional market growth. Increasing awareness of home healthcare and expanding access to advanced infusion technologies further strengthen market expansion.

China Home Infusion Therapy Market Insights

China's market accounted for USD 3.45 billion in 2025, representing the largest share within Asia Pacific. Expanding healthcare infrastructure, increasing demand for home-based care, growing chronic disease burden, and rising investments in healthcare technologies continue to drive market expansion.

Japan Home Infusion Therapy Market Insights

Japan's market generated USD 1.48 billion in 2025. Increasing elderly population, growing demand for home healthcare, expanding adoption of portable infusion devices, and rising healthcare modernization continue to support market growth.

Middle East and Africa Home Infusion Therapy Market Analysis

Middle East and Africa home infusion therapy market accounted for 4.1% of the global market, totaling USD 1.71 billion in 2025, and is projected to grow at a CAGR of 7.4% during the forecast period. Increasing investments in healthcare infrastructure, growing prevalence of chronic diseases, expanding home healthcare services, and rising awareness of home-based treatment options continue to support regional market growth.

UAE Home Infusion Therapy Market Insights

The UAE market was valued at USD 0.43 billion in 2025. Increasing investments in advanced healthcare infrastructure, growing demand for home-based medical services, expanding private healthcare facilities, and rising adoption of innovative infusion technologies continue to drive market growth.

Africa Home Infusion Therapy Market Insights

Africa's market reached USD 1.28 billion in 2025. Expanding healthcare access, increasing investments in healthcare infrastructure, growing demand for affordable home-based treatment, and rising awareness of infusion therapy continue to create long-term growth opportunities across the region.

List of Key and Emerging Players in Home Infusion Therapy Market

Baxter
Braun SE
BD
Fresenius Kabi AG
ICU Medical, Inc.
Terumo Corporation
JMS Co. Ltd.
Option Care Health, Inc.
CareCentrix, Inc.
Coram LLC.
PharMerica Corporation
Moog Inc.
Amedisys, Inc.

Key Industry Developments

June 2026
Option Care Health expanded its home infusion therapy services through new healthcare partnerships and service enhancements. The company focused on improving access to infusion care at home through digital monitoring, clinical support, and patient-centered care models.
March 2026
CVS Health’s Coram expanded its home infusion therapy capabilities with enhanced specialty infusion services and care coordination solutions. The initiatives support patients requiring long-term infusion treatments outside traditional hospital settings.
January 2026
Optum Infusion Pharmacy expanded its home infusion services portfolio with improved specialty pharmacy and infusion management solutions. The company focused on increasing patient access to personalized infusion care and remote support services.
October 2025
Amerita expanded its home infusion therapy network through new service locations and healthcare collaborations. The expansion supports broader availability of specialty infusion treatments for chronic and complex conditions.

Report Scope

Segmentation

By Type 2
  • Products
  • Services
By Product 4
  • Infusion Pumps
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors
By Application 7
  • Anti-Infective
  • Endocrinology
  • Hydration Therapy
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Baxter · Braun SE · BD · Fresenius Kabi AG · ICU Medical, Inc.
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The home infusion therapy market size is valued at USD 44.99 Billion in 2026 and is projected to reach USD 83.47 Billion by 2034, at a CAGR of 8.03% during the forecast period 2026-2034.

North America dominated the market with a share of 42.6% in 2025.

The leading players in this market are Baxter, Braun SE, BD, Fresenius Kabi AG, ICU Medical.

The home infusion therapy market is projected to grow at a CAGR of 8.03% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: